A

argenx

Develops antibody-based therapies for autoimmune diseases

Early Development Global Regulatory Lead

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • At least 15 years of regulatory affairs experience within biopharmaceutical organizations, including 5–7 years in global leadership roles focused on major regulatory regions such as the FDA, EMA, or PMDA.
  • Strong understanding of drug development, with direct experience in early clinical development, first-in-human studies, orphan drugs, and regulatory strategy for innovative medicines.
  • Ability to develop fit-for-purpose global regulatory strategies that support early asset progression, regulatory interactions, and informed development decisions.
  • Regulatory experience across early and late clinical development phases, supporting continuity from discovery and first-in-human studies through later-stage development.
  • Experience interacting with regulatory authorities, including scientific advice, IND/CTA activities, expedited pathways, and other early development regulatory milestones.
  • Ability to engage credibly with scientists, clinicians, and cross-functional development teams.
  • Complementary expertise across modalities, including antibodies, peptides, siRNA, and small molecules.
  • Experience integrating biomarker strategy, patient engagement, and patient-relevant evidence into regulatory and development plans.
  • Strong understanding of current and evolving global regulations, guidelines, regulatory expectations, and healthcare business practices relevant to early and late clinical development globally.
  • Strong written, verbal, and presentation skills and the ability to translate complex regulatory topics into practical business recommendations.
  • Organizational and project management skills, including the ability to prioritize, delegate, and manage multiple workstreams in a fast-paced environment.
  • Matrix leadership skills, including the ability to build relationships, influence stakeholders, build, motivate, and develop teams, and drive outcomes.
  • Ability to combine strategic thinking with hands-on execution and deliver high-quality work under challenging timelines.
  • Candidates must be located in the US Eastern Time timezone, Belgium, or Switzerland.

Responsibilities

  • Serve as a key member of the global Early Development regulatory team and help establish and grow the team in alignment with company culture.
  • Provide global regulatory leadership for assigned early development programs, ensuring clear regulatory strategy, risk identification, and cross-functional alignment.
  • Co-create and implement global regulatory strategies to deliver expedited development milestones through the end of first-in-human studies, aligned with commercial objectives.
  • Ensure patient-centricity is embedded in regulatory strategy.
  • Represent the Early Development regulatory team in early development governance forums and provide timely, consistent regulatory input to stakeholders to support business decisions.
  • Serve as the conduit between the Early Development regulatory team and asset teams to facilitate smooth program transitions.
  • Partner with the Early Development Regulatory Lead to develop and implement infrastructure and process improvements.
  • Mentor and coach members of the Early Development regulatory team.
  • Build relationships with internal stakeholders.
  • Work with regulatory intelligence and policy teams to monitor, interpret, and communicate evolving global regulatory requirements.
  • Oversee regulatory affairs vendors involved in Early Development regulatory team activities and ensure high-quality interactions with regulators.
  • Work with other Early Development teams and contribute hands-on to regulatory filings, including Scientific Advice, INDs, and other areas as requested.

Desired Qualifications

  • An advanced scientific degree, such as a PhD or PharmD.
  • Scientific depth in immunology; broader experience across therapeutic areas and indications is an advantage.
  • Experience supporting cross-functional business development due diligence and providing regulatory assessments for investment and portfolio decisions.
  • Interest in applying artificial intelligence and digital tools to improve regulatory strategy, regulatory intelligence, document preparation, and ways of working.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs